Thursday, April 3, 2025
4/3/2025
Novel tools for measuring typhoid vaccine impact - Project Summary Typhoid fever is a leading cause of invasive bacterial illness and death worldwide, with the majority of infections occurring in low- and middle-income countries where water and sanitation infrastructure is poor. Highly antimicrobial-resistant strains of Salmonella Typhi have been emerging and spreading internationally and intercontinentally, posing the risk of rising morbidity among reduced effectiveness of therapy. New typhoid conjugate vaccines have demonstrated a high level of effectiveness and are recommended by the WHO; however, many countries lack data on typhoid incidence, as the only reliable tool for typhoid diagnosis—blood culture—is not widely available in many resource-constrained settings where typhoid risk may be greatest. To address these gaps, we propose to leverage a large, cluster-randomized trial of a typhoid conjugate vaccine being performed in Vellore, India, to test three emerging tools to measure community burden of typhoid: 1) seroepidemiological models, utilizing recently characterized seroresponses to S. Typhi antigens; 2) detection of S. Typhi-specific bacteriophages in wastewater, using low-cost assays; 3) phylodynamic methods that track measures of transmission intensity. This project will provide rigorous testing of multiple innovative methods amid uniquely intensive clinical surveillance in a vaccine trial. Overall, this project will address a critical need for public health tools to make typhoid surveillance scalable in resource-constrained settings, to inform vaccine introductions and monitor their impact.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).